CRITICALFEDGLP-1 Compounding2025-09-10

FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy

Med spas must act on the GLP-1 product recall now!

What to do

Free

Enter your email to unlock “What to do” on every alert — and get the weekly Brief. No charge.

Want it filtered to YOUR states + real-time alerts? Become a member →

FDA Enforcement · primary source ↗

Related alerts

Monitoring, not legal advice.